Crystal Denlinger: Honored that Kimryn Rathmell joined NCCN as the keynote speaker for Patient Advocacy Summit
Crystal Denlinger, Chief Executive Officer at National Comprehensive Cancer Network, shared a post on LinkedIn:
“Honored that Dr. W. Kimryn Rathmell, Director of the National Cancer Institute (NCI) joined National Comprehensive Cancer Network (NCCN) as the keynote speaker for today’s Patient Advocacy Summit Better Information for Better Outcomes: Policy and Practice Strategies for Patient Education.
Trusted, reliable information from organizations like ours are key to better cancer-related and patient outcomes for everyone.”
More posts featuring Crystal Denlinger.
Dr. Crystal Denlinger, MD, serves as the Chief Executive Officer at the National Comprehensive Cancer Network (NCCN) and is a medical oncologist specializing in gastrointestinal malignancies.
Her professional interests include clinical trials, clinical practice guidelines, cancer survivorship, gastrointestinal cancers, and early-phase drug development. She also holds the position of Adjunct Medical Oncologist at Fox Chase Cancer Center.
Dr. Kimryn Rathmell serves as the director of the National Cancer Institute. She is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers.
She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023